#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12892	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2141	591.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	699	C,A	687,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12892	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2141	591.0	0	HET	.	.	.	C207T	.	207	207	C	433	433	C	706	C,T	544,124	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23290	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3683	624.5	0	.	n	.	0	T695C	SNP	695	695	T	1145	1145	C	691	C,T	667,11	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23290	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3683	624.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2421	2421	C	710	C,A	690,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23290	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3683	624.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2495	2495	A	717	A	703	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23290	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3683	624.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3047	3047	C	664	C,A	653,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23290	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3683	624.5	0	HET	.	.	.	A1638G	.	1638	1638	A	2088	2088	A	727	A,G	398,315	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	998	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1541	64.3	0	.	p	.	0	M180T	NONSYN	538	540	ATG	884	886	ACG	86;86;91	A;C;G	85;85;90	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1674	folP	855	855	100.0	folP.l15.c17.ctg.1	1636	101.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1080	1082	AGC	184;182;184	A;G;C	181;179;178	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3894	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3323	115.6	1	SNP	p	S91F	1	.	.	271	273	TTC	543	545	TTC	135;136;139	T;T;C,A	131;136;137,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3894	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3323	115.6	1	SNP	p	D95G	1	.	.	283	285	GGC	555	557	GGC	131;131;130	G;G;C,G	127;130;127,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3894	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3323	115.6	1	SNP	p	G95N	0	.	.	283	285	GGC	555	557	GGC	131;131;130	G;G;C,G	127;130;127,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1508	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1349	110.3	1	SNP	p	G45D	0	.	.	133	135	GGC	477	479	GGC	196;193;193	G;G;C	192;189;187	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	792	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	978	80.0	0	.	n	.	0	A197.	DEL	197	197	A	593	593	A	150	A	144	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3982	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	129.1	1	SNP	p	D86N	0	.	.	256	258	GAC	645	647	GAC	156;156;156	G;A;C	154;149;156	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3982	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	129.1	1	SNP	p	R87W	0	.	.	259	261	CGT	648	650	CGT	156;157;158	C,A;G;T	155,1;154;153	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3982	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	129.1	1	SNP	p	R87I	0	.	.	259	261	CGT	648	650	CGT	156;157;158	C,A;G;T	155,1;154;153	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3982	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	129.1	1	SNP	p	S87R	1	.	.	259	261	CGT	648	650	CGT	156;157;158	C,A;G;T	155,1;154;153	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3982	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	129.1	1	SNP	p	S88P	0	.	.	262	264	TCC	651	653	TCC	156;155;155	T;C;C	153;151;153	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3528	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2813	123.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1633	1635	GGC	184;180;179	G;G;C	181;177;173	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1258	1260	GCC	189;191;193	G;C;C	182;187;189	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1261	1263	ATG	194;193;191	A;T;G	191;187;186	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1273	1275	ACC	188;187;186	A,G;C,T;C	180,1;180,1;182	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1273	1275	ACC	188;187;186	A,G;C,T;C	180,1;180,1;182	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1774	1776	ACC	156;158;159	A;C;C	146;155;155	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1828	1830	GCG	165;163;163	G;C,G;G	161;159,1;159	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1828	1830	GCG	165;163;163	G;C,G;G	161;159,1;159	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1951	1953	GGT	128;128;127	G;G;T,C	124;123;120,4	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1960	1962	AGC	121;122;122	A,G;G;C	113,5;121;117	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3350	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2400	137.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1978	1980	CCG	91;92;92	C;C;G,C	83;86;82,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4796	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3162	149.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1691	1693	CCG	149;144;143	C;C,T;G	134;137,3;133	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1902	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1870	100.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	644	644	C	126	C,G	118,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1453	176.8	0	.	p	.	0	I45V	NONSYN	133	135	ATT	377	379	GTT	197;196;193	G,A;T,G;T	190,7;191,3;191	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1453	176.8	1	SNP	p	G120K	1	.	.	358	360	AAG	602	604	AAG	199;199;204	A,G;A,G;G,C	193,1;195,1;192,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1453	176.8	1	SNP	p	N121D	0	.	.	361	363	AAC	605	607	AAC	202;202;203	A,G;A;C,A	196,2;200;196,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1453	176.8	1	SNP	p	A121N	1	.	.	361	363	AAC	605	607	AAC	202;202;203	A,G;A;C,A	196,2;200;196,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8664	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4936	173.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	862	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1190	71.9	1	SNP	p	V57M	1	.	.	169	171	ATG	684	686	ATG	150;150;152	A;T;G	149;148;150	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
